Pharma Technology Focus – Issue 53
In this issue: Pfizer ’s acquisition of AstraZeneca’s antibiotics unit, new ideas to tackle antimicrobial resistance, vaccines to look out for in 2017, targeting Tourette syndrome, using ketamine to treat depression, and more.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Antimicrobial Resistance | Depression | Mergers and Aquisitions | Pfizer | Pharmaceuticals | Tourette Syndrome | Vaccines